
From an Olympic gold medal win for cancer survivor Max Parrot to Sofía Vergara’s candidness about her cancer journey, here’s what’s happening in the cancer landscape this week.

From an Olympic gold medal win for cancer survivor Max Parrot to Sofía Vergara’s candidness about her cancer journey, here’s what’s happening in the cancer landscape this week.

A metastatic breast cancer survivor honors another survivor whom she was inspired by through social media for her contributions to helping others who have lost their hair during cancer treatment and spreading positivity.

The MEK inhibitor trametinib should be considered a new standard of care for patients with a rare subtype of ovarian cancer, explains an expert from The University of Texas MD Anderson Cancer Center.

A colleague honors Dr. Nancy U. Lin for her dedication to improving outcomes for patients with metastatic breast cancer by creating a team of neuro experts to help women with brain metastases.

As I sit here watching the Winter Olympics, I am immediately reminded of all the ways in which my grueling and stressful journey with cancer feels akin to the struggles of these Olympic athletes.

On this episode of the “Cancer Horizons” podcast, former NFL linebacker Chris Draft discusses his wife’s experience with cancer, which led to her untimely death, and describes why advocacy is so important in the cancer world, especially with Cancer Moonshot bringing disparities to the forefront.

A senior clinical trial coordinator and research trial nurse is honored for gently guiding patients with cancer through the entire clinical trial process with empathy and devotion.

A phase 3 trial evaluating the safety and efficacy of the BTK inhibitor LOXO-305 in patients with previously treated mantle cell lymphoma is now open to patients across more than a dozen states.

As the number of cancer diagnoses continues to rise in the United States, the relaunch of President Joe Biden’s Cancer Moonshot is needed now more than ever, explained an expert at Hackensack Meridian John Theurer Cancer Center.

As I remember my wonderful service dog, Sita, and honor her life, I want her to know that she not only taught me how to live, but also how to die gracefully.

The executive director of the National LGBT Cancer Network discussed the past two decades of positive change in LGBTQ cancer care and highlighted what more still needs to be done.

One woman created an accessible and affordable business to help women regain confidence after breast cancer surgery through prosthetics.

Results from the SIENDO trial examining the effects of Xpovio as a frontline maintenance therapy in patients with advanced or recurrent endometrial cancer highlighted a significant survival benefit.

“Coping for me has been routine-based, and that is making sure I do the things that are in my day that are really foundationally making me feel joyful,” says a survivor of an advanced-stage cancer on how to cope with “scanxiety.”

After my cancer diagnosis, I was thrust into a world where I rarely understood what was happening to me. An easy-to-understand “cancer vocabulary” would have surely eased my confusions.

Patients with cancer, their friends and families can enjoy these guilt-free recipes when sitting down to watch the Los Angeles Rams and Cincinnati Bengals go toe-to-toe during Super Bowl 56 on Sunday.

A retired teacher with breast cancer is recognized for her dedication to raising money and awareness for metastatic breast cancer by swimming across as many lakes as possible.

A phase 2b clinical trial evaluating the efficacy and safety of an immunotherapy drug for patients with brain cancer has opened at Roswell Park Comprehensive Cancer Center in Buffalo, New York, with additional plans to be carried out at more than a dozen sites.

After the death of his wife, former NFL linebacker Chris Draft has been advocating for improvements for all patients with cancer — a mission that perfectly aligns with the recently relaunched Cancer Moonshot initiative.

A breast cancer survivor explains why she was inspired to donate her hair to make wigs for children with cancer 11 years after she lost her own hair during chemotherapy treatments.

Treatment with a combination of PD-1 inhibition, minimally invasive chemotherapy and Lenvima improved outcomes for patients with unresectable liver cancer compared to PD-1 inhibition and Lenvima alone.

A pancreatic cancer survivor explains why hearing the news that someone else has cancer makes it difficult for him to engage in the conversation, as it reminds him of his experience.

After receiving a breast cancer diagnosis at age 43, one woman became involved in advocacy with SHARE Cancer Support, spending hours speaking to women on the phone about treatments, emotional impacts and personal issues related to their breast cancer.

A mother of a breast cancer survivor who has lost loved ones to the disease explains why the phrase “living with cancer” doesn’t make sense, because there is no escape from it after diagnosis.

A colleague explains how one woman transformed the devastation of her breast cancer diagnosis into a “war strategy” of advocacy, starting at her kitchen table.

After four years of additional follow-up, survival continued to improve and side effects remained tolerable in patients with anaplastic thyroid cancer receiving Tafinlar plus Mekinist.

In honor of World Cancer Day, experts from the National Comprehensive Cancer Network discussed efforts to reduce disparities in cancer care across the United States.

I was hesitant to glance at myself in the mirror in the year after my breast cancer surgery. But I soon learned that I was more than just my image, and I encourage others to do the same.

From the death of a former New York Mets player due to cancer, to a lawsuit against Tokyo Electric Power Company Holdings regarding cancer potentially caused by the 2011 Fukushima nuclear disaster, here’s what’s happening in the cancer landscape this week.

A colleague describes an oncology nurse who goes above and beyond as both a dedicated nurse to her patients’ care and an advocate in the field of metastatic breast cancer.